Biomarkers and surrogate end points in clinical trials of tuberculosis treatment.
Davies
Geraint Rhys
GR
Phillips
Patrick P J
PP
Nunn
Andrew J
AJ
D000995:Antitubercular Agents / Q000627:therapeutic use*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D006801:Humans; D012008:Recurrence; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000473:pathology
D000995:Antitubercular Agents; D015415:Biomarkers